Skip to content

Agilon Health AGL Medical services revenue — Change in revenue recognized

Similar metrics at other companies

Allient Inc. logo
ALNTMedical — Revenue
$19.47M+1.9%
TransMedics Group, Inc. logo
TMDXService — Revenue
$65.96M+19.3%
Ryder System logo
RServices revenue — Revenue
$2.06B-0.8%
CVS Health logo
CVSServices — Revenue
$3.84B+7.2%
CVS Health logo
CVSHealth Services — Revenue
$48.24B+11.0%
DXP Enterprises logo
DXPEService Center — Revenue change
$10.9M

Other financials

Income statement

See full
Revenue$1.4B-7.3%
Operating income$4.0M+118%
Net income$48.9M+304%
EPS (diluted)$2.94+303%

Balance sheet

See full
Cash & equivalents$211.6M+52.6%
Total debt$33.4M-20.5%
Total equity$181.4M-63.7%
Total assets$1.5B-22.1%

Cash flow

See full
Operating cash flow$23.7M+174%
CapEx$3.1M-19.4%
Free cash flow$20.6M+158%

Valuation

See full
Market cap$1.78B-92.6%

Profitability

See full
Operating margin-7.5%+6.5pp
Net margin-6.1%+6.3pp
FCF margin-1.1%

Returns & leverage

See full
Return on equity-104%-291pp
Debt / equity0.2×+0.1×
Current ratio-0.2×

Where this comes from

Reported directly by Agilon Health in its filing.

Tagged under the XBRL concept agl:ConcentrationRiskPercentageChangeInRevenueRecognized.

The official record: Agilon Health’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Agilon Health's medical services revenue — change in revenue recognized.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Agilon Health's medical services revenue — change in revenue recognized?
Agilon Health (AGL) reported medical services revenue — change in revenue recognized of 1% in Q1 2026.
What does medical services revenue — change in revenue recognized mean?
Measures the period-over-period variance in revenue recognized from the medical services segment. This metric highlights the growth trajectory or contraction of the segment's financial performance. It provides investors with insight into the company's ability to scale its physician partnerships and manage patient populations effectively over time.